In 2023, South Africa's pharmaceutical industry export market share stood at 0.070. Forecasts for 2024 predict a slight decline to 0.069, stabilizing at 0.068 from 2025 to 2028. This signifies a minor decline over the next five years.

Year-on-year evaluations show a -1.43% change from 2023 to 2024 and a consistent performance with no further declines through 2028. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 indicates an average annual reduction of approximately -0.29%.

Future trends to watch for include increasing competition from other markets, regulatory changes, and potential shifts in global pharmaceutical demand which could affect South Africa's export market share.